Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,389 | 36,810 | 58,726 | 54,428 | 61,033 |
| Receivables | 48,923 | 44,361 | 36,145 | 45,468 | 39,241 |
| Inventories | 9,480 | 7,489 | 5,481 | 6,617 | 8,930 |
| TOTAL | $125,115 | $103,498 | $112,545 | $119,348 | $124,069 |
| Non-Current Assets | |||||
| PPE Net | 1,329 | 1,527 | 1,678 | 1,915 | 2,172 |
| Intangibles | 207,554 | 216,054 | 179,143 | 186,318 | 193,536 |
| Other Non-Current Assets | 5,137 | 5,468 | 5,939 | 4,435 | 5,647 |
| TOTAL | $214,020 | $223,049 | $186,760 | $192,668 | $201,355 |
| Total Assets | $339,135 | $326,547 | $299,305 | $312,016 | $325,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,271 | 12,174 | 12,257 | 12,222 | 12,338 |
| Accounts payable and accrued liabilities | 8,523 | 6,685 | 11,859 | 18,226 | 15,012 |
| Accrued Expenses | 70,974 | 67,361 | 57,612 | 67,975 | 69,703 |
| Other current liabilities | 46,759 | 48,799 | 18,752 | 18,491 | 12,037 |
| TOTAL | $138,527 | $135,019 | $100,480 | $116,914 | $109,090 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,250 | 61,319 | 66,410 | 66,751 | 71,834 |
| Other Non-Current Liabilities | 27,496 | 27,795 | 35,555 | 36,086 | 39,197 |
| TOTAL | $88,746 | $89,114 | $101,965 | $102,837 | $111,031 |
| Total Liabilities | $227,273 | $224,133 | $202,445 | $219,751 | $220,121 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,030 | 3,024 | 2,977 | 2,968 | 2,898 |
| Common Shares | 4 | 4 | 4 | 4 | 18 |
| Retained earnings | -420,162 | -429,226 | -433,833 | -437,570 | -423,401 |
| TOTAL | $111,862 | $102,414 | $96,860 | $92,265 | $105,303 |
| Total Liabilities And Equity | $339,135 | $326,547 | $299,305 | $312,016 | $325,424 |